BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32505795)

  • 1. Electroporation-enhanced transdermal drug delivery: Effects of logP, pK
    Chen X; Zhu L; Li R; Pang L; Zhu S; Ma J; Du L; Jin Y
    Eur J Pharm Sci; 2020 Aug; 151():105410. PubMed ID: 32505795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal permeation of drugs with differing lipophilicity: Effect of penetration enhancer camphor.
    Xie F; Chai JK; Hu Q; Yu YH; Ma L; Liu LY; Zhang XL; Li BL; Zhang DH
    Int J Pharm; 2016 Jun; 507(1-2):90-101. PubMed ID: 27154251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Umbilical therapy for promoting transdermal delivery of topical formulations: Enhanced effect and underlying mechanism.
    Yang C; Peng X; Shi Y; Zhang Y; Feng M; Tian Y; Zhang J; Cen S; Li Z; Dai X; Jing Z; Shi X
    Int J Pharm; 2024 Mar; 652():123834. PubMed ID: 38262583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical Penetration Enhancers for Transdermal Drug Delivery - Success and Challenges.
    Ita KB
    Curr Drug Deliv; 2015; 12(6):645-51. PubMed ID: 26239423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced transdermal drug delivery techniques: an extensive review of patents.
    Rizwan M; Aqil M; Talegaonkar S; Azeem A; Sultana Y; Ali A
    Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):105-24. PubMed ID: 19519571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration enhancement of transdermal delivery--current permutations and limitations.
    Purdon CH; Azzi CG; Zhang J; Smith EW; Maibach HI
    Crit Rev Ther Drug Carrier Syst; 2004; 21(2):97-132. PubMed ID: 15202928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of essential oil from Mentha haplocalyx and menthol used as penetration enhancers].
    Lan Y; Wang JY; Tao Y; Ru QG; Wang YF; Yu JX; Liu Y; Wu Q
    Zhongguo Zhong Yao Za Zhi; 2016 Apr; 41(8):1516-1522. PubMed ID: 28884549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal delivery of nalbuphine and its prodrugs by electroporation.
    Sung KC; Fang JY; Wang JJ; Hu OY
    Eur J Pharm Sci; 2003 Jan; 18(1):63-70. PubMed ID: 12554074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of borneol on the transdermal permeation of drugs with differing lipophilicity and molecular organization of stratum corneum lipids.
    Yi QF; Yan J; Tang SY; Huang H; Kang LY
    Drug Dev Ind Pharm; 2016; 42(7):1086-93. PubMed ID: 26635061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electroporation: an avenue for transdermal drug delivery.
    Charoo NA; Rahman Z; Repka MA; Murthy SN
    Curr Drug Deliv; 2010 Apr; 7(2):125-36. PubMed ID: 20158490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of voltage gated transdermal drug delivery platform to impose synergistic enhancement in skin permeation using electroporation and gold nanoparticle.
    Anirudhan TS; Nair SS
    Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():437-446. PubMed ID: 31147014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.
    Kanikkannan N; Kandimalla K; Lamba SS; Singh M
    Curr Med Chem; 2000 Jun; 7(6):593-608. PubMed ID: 10702628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical, magnetic, photomechanical and cavitational waves to overcome skin barrier for transdermal drug delivery.
    Wong TW
    J Control Release; 2014 Nov; 193():257-69. PubMed ID: 24801250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Science of, and insights into, thermodynamic principles for dermal formulations.
    Tapfumaneyi P; Imran M; Alavi SE; Mohammed Y
    Drug Discov Today; 2023 Apr; 28(4):103521. PubMed ID: 36754143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of nanovesicles and physical methods for enhanced transdermal delivery of a model hydrophilic drug.
    Zorec B; Zupančič Š; Kristl J; Pavšelj N
    Eur J Pharm Biopharm; 2018 Jun; 127():387-397. PubMed ID: 29581043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of maximum transdermal flux of nonionized xenobiotics from basic physicochemical determinants.
    Milewski M; Stinchcomb AL
    Mol Pharm; 2012 Jul; 9(7):2111-20. PubMed ID: 22702370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular mechanism investigation of the transdermal/topical absorption classification system on the basis of drug skin permeation and skin retention.
    Tian Q; Quan P; Fang L; Xu H; Liu C
    Int J Pharm; 2021 Oct; 608():121082. PubMed ID: 34506925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microemulsions as transdermal drug delivery vehicles.
    Kogan A; Garti N
    Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery.
    Wang Y; Thakur R; Fan Q; Michniak B
    Eur J Pharm Biopharm; 2005 Jul; 60(2):179-91. PubMed ID: 15939232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.